Follow
Jeffrey Willis
Title
Cited by
Cited by
Year
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two …
CC Wykoff, F Abreu, AP Adamis, K Basu, DA Eichenbaum, Z Haskova, ...
The Lancet 399 (10326), 741-755, 2022
2542022
Deep learning algorithm predicts diabetic retinopathy progression in individual patients
F Arcadu, F Benmansour, A Maunz, J Willis, Z Haskova, M Prunotto
NPJ digital medicine 2 (1), 92, 2019
2542019
Characterizing disease burden and progression of geographic atrophy secondary to age-related macular degeneration
U Chakravarthy, CC Bailey, RL Johnston, M McKibbin, RS Khan, ...
Ophthalmology 125 (6), 842-849, 2018
1972018
The prevalence of concurrent hearing and vision impairment in the United States
BK Swenor, PY Ramulu, JR Willis, D Friedman, FR Lin
JAMA internal medicine 173 (4), 312-313, 2013
1882013
Vision-related functional burden of diabetic retinopathy across severity levels in the United States
JR Willis, QV Doan, M Gleeson, Z Haskova, P Ramulu, L Morse, ...
JAMA ophthalmology 135 (9), 926-932, 2017
1472017
Progression from early/intermediate to advanced forms of age-related macular degeneration in a large UK cohort: rates and risk factors
U Chakravarthy, CC Bailey, PH Scanlon, M McKibbin, RS Khan, ...
Ophthalmology Retina 4 (7), 662-672, 2020
1432020
Gender differences in perception and care-seeking for illness of newborns in rural Uttar Pradesh, India
JR Willis, V Kumar, S Mohanty, P Singh, V Singh, AH Baqui, S Awasthi, ...
Journal of health, population, and nutrition 27 (1), 62, 2009
1302009
Visual impairment, uncorrected refractive error, and accelerometer-defined physical activity in the United States
JR Willis, JL Jefferys, S Vitale, PY Ramulu
Archives of ophthalmology 130 (3), 329-335, 2012
1162012
Visual field loss and accelerometer-measured physical activity in the United States
SW Van Landingham, JR Willis, S Vitale, PY Ramulu
Ophthalmology 119 (12), 2486-2492, 2012
1012012
Visual impairment, uncorrected refractive error, and objectively measured balance in the United States
JR Willis, SE Vitale, Y Agrawal, PY Ramulu
JAMA ophthalmology 131 (8), 1049-1056, 2013
752013
Deep learning predicts OCT measures of diabetic macular thickening from color fundus photographs
F Arcadu, F Benmansour, A Maunz, J Michon, Z Haskova, D McClintock, ...
Investigative ophthalmology & visual science 60 (4), 852-857, 2019
672019
The prevalence of myopic choroidal neovascularization in the United States: analysis of the IRIS® data registry and NHANES
JR Willis, S Vitale, L Morse, DW Parke II, WL Rich, F Lum, RA Cantrell
Ophthalmology 123 (8), 1771-1782, 2016
602016
The cost-effectiveness of a child nutrition education programme in Peru
HR Waters, ME Penny, HM Creed-Kanashiro, RC Robert, R Narro, J Willis, ...
Health Policy and Planning 21 (4), 257-264, 2006
532006
Treatment patterns for diabetic macular edema: an intelligent research in sight (IRIS®) registry analysis
RA Cantrell, F Lum, Y Chia, LS Morse, WL Rich, CA Salman, JR Willis
Ophthalmology 127 (3), 427-429, 2020
382020
Treatment patterns for myopic choroidal neovascularization in the United States: analysis of the IRIS registry
J Willis, L Morse, S Vitale, DW Parke II, WL Rich, F Lum, RA Cantrell
Ophthalmology 124 (7), 935-943, 2017
322017
Determination of extended-interval gentamicin dosing for neonatal patients in developing countries
GL Darmstadt, MM Hossain, AK Jana, SK Saha, Y Choi, S Sridhar, ...
The Pediatric infectious disease journal 26 (6), 501-507, 2007
322007
Development of deep learning models to predict best-corrected visual acuity from optical coherence tomography
MG Kawczynski, T Bengtsson, J Dai, JJ Hopkins, SS Gao, JR Willis
Translational vision science & technology 9 (2), 51-51, 2020
292020
YOSEMITE and RHINE: phase 3 randomized clinical trials of faricimab for diabetic macular edema: study design and rationale
N Eter, RP Singh, F Abreu, K Asik, K Basu, C Baumal, A Chang, KG Csaky, ...
Ophthalmology Science 2 (1), 100111, 2022
252022
TENAYA and LUCERNE: rationale and design for the phase 3 clinical trials of faricimab for neovascular age-related macular degeneration
AM Khanani, RH Guymer, K Basu, H Boston, JS Heier, JF Korobelnik, ...
Ophthalmology Science 1 (4), 100076, 2021
252021
Disrupting the ventral premotor cortex interferes with the contribution of action observation to use-dependent plasticity
G Cantarero, JM Galea, L Ajagbe, R Salas, J Willis, P Celnik
Journal of cognitive neuroscience 23 (12), 3757-3766, 2011
242011
The system can't perform the operation now. Try again later.
Articles 1–20